Literature DB >> 9306933

Numerical chromosomal aberrations in Hodgkin's disease detected by in situ hybridisation on routine paraffin sections.

J H Pringle1, J A Shaw, A Gillies, I Lauder.   

Abstract

AIMS: To visualise directly numerical chromosomal aberrations and polyploidy in both Hodgkin and Reed Sternberg (HRS) cells and background cells from cases of Hodgkin's disease using in situ hybridisation.
METHODS: Non-isotopic DNA in situ hybridisation was applied to interphase cell nuclei of Hodgkin's disease within routine paraffin embedded tissue sections. Two a satellite DNA probes, specific for chromosomes 3 and 12, were used to evaluate the feasibility of this approach. Double labelling with immunocytochemical detection of the CD30 antigen was used to identify HRS cells. Cytogenetic normal diploid and triploid placental tissue served as controls.
RESULTS: The eight cases of Hodgkin's disease investigated displayed frequent polysomy, while the majority of background cells showed disomy signals.
CONCLUSIONS: Numerical chromosomal aberrations were detected in HRS cells from eight cases of Hodgkin's disease by in situ hybridisation. These data show that in Hodgkin's disease HRS cells frequently display polyploidy compared with background cells and are, therefore, probably the only neoplastic component in this disease. Correlations between polysomy and tumour type or grade could not be made from these data owing to the limited number of cases examined and to problems with interpreting data from truncated nuclei.

Entities:  

Mesh:

Year:  1997        PMID: 9306933      PMCID: PMC500048          DOI: 10.1136/jcp.50.7.553

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte.

Authors:  F Cabanillas; S Pathak; J Trujillo; G Grant; A Cork; F B Hagemeister; W S Velasquez; P McLaughlin; J Redman; R Katz
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

2.  Immunoglobulin gene rearrangements in Hodgkin's disease.

Authors:  L M Weiss; J G Strickler; E Hu; R A Warnke; J Sklar
Journal:  Hum Pathol       Date:  1986-10       Impact factor: 3.466

3.  In situ hybridization: alkaline phosphatase visualization of biotinylated probes in cryostat and paraffin sections.

Authors:  J H Pringle; C E Homer; A Warford; C H Kendall; I Lauder
Journal:  Histochem J       Date:  1987-09

Review 4.  Hodgkin's disease. Lineage and clonality.

Authors:  W C Chan; J Delabie
Journal:  Am J Clin Pathol       Date:  1995-10       Impact factor: 2.493

5.  Chromosomes in Hodgkin's disease.

Authors:  J D Rowley
Journal:  Cancer Treat Rep       Date:  1982-04

6.  Recurring chromosome abnormalities in Hodgkin's disease.

Authors:  H Döhner; C D Bloomfield; G Frizzera; J Frestedt; D C Arthur
Journal:  Genes Chromosomes Cancer       Date:  1992-11       Impact factor: 5.006

7.  The Reed-Sternberg cells of Hodgkin disease are clonal.

Authors:  G Inghirami; L Macri; S Rosati; B Y Zhu; H T Yee; D M Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

8.  Histological preservation after in situ hybridization to archival solid tumour sections allows discrimination of cells bearing numerical chromosome changes.

Authors:  H van Dekken; H M Kerstens; T A Tersteeg; A A Verhofstad; G P Vooijs
Journal:  J Pathol       Date:  1992-11       Impact factor: 7.996

9.  Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease.

Authors:  K Weber-Matthiesen; J Deerberg; M Poetsch; W Grote; B Schlegelberger
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Numerical aberrations of chromosomes 1 and 7 in renal cell carcinomas as detected by interphase cytogenetics.

Authors:  J L Beck; A H Hopman; W F Feitz; J Schalken; H E Schaafsma; C A Van de Kaa; F C Ramaekers; A G Hanselaar; P C De Wilde
Journal:  J Pathol       Date:  1995-06       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.